Impact of chemotherapy dose-related factors on survival in breast cancer patients treated with adjuvant anthracycline-based chemotherapy.

被引：0
|
作者：
Chirivella, I. [1 ]
Bermejo, B. [1 ]
Insa, A. [1 ]
Perez-Fidalgo, A. [1 ]
Magro, A. [1 ]
Rosello, S. [1 ]
Garcia-Garre, E. [1 ]
Martin, P. [1 ]
Bosch, A. [1 ]
Lluch, A. [1 ]
机构：
[1] Hosp Clin Univ Valencia, Valencia, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：44S / 44S
页数：1
相关论文
共 50 条
  • [1] Anthracycline-based adjuvant chemotherapy in breast cancer
    Gray, Richard
    LANCET, 2010, 375 (9729): : 1870 - 1871
  • [2] Adjuvant anthracycline-based chemotherapy for early breast cancer: do the dose and schedule matter?
    Mano, MS
    Awada, A
    Kerr, J
    Canney, P
    CANCER TREATMENT REVIEWS, 2005, 31 (02) : 69 - 78
  • [3] ANTHRACYCLINE-BASED CHEMOTHERAPY FOR BREAST CANCER - PREDICTIVE FACTORS OF DOSE INTENSITY REDUCTION
    Faustino, C.
    Afonso, N.
    Sousa, B.
    Rodrigues, H.
    ANNALS OF ONCOLOGY, 2008, 19 : 82 - 82
  • [4] Benefits of dexrazoxane in female patients with stage II breast cancer treated with anthracycline-based adjuvant chemotherapy
    Schnirer, I. I.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [5] Dose and dose intensity effect of adjuvant anthracycline-based chemotherapy in early breast cancer -: A retrospective analysis
    Amador, ML
    Jimeno, A
    Hitt, R
    Cortés-Funes, H
    Colomer, R
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2004, 27 (03): : 269 - 273
  • [6] Mitotic index and benefit of adjuvant anthracycline-based chemotherapy in patients with early breast cancer
    Andre, F
    Khalil, A
    Slimane, K
    Massard, C
    Mathieu, MC
    Vignot, S
    Assi, H
    Delaloge, S
    Spielmann, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (13) : 2996 - 3000
  • [7] Concomitant radiotherapy, and anthracycline-based chemotherapy in adjuvant breast cancer treatment
    Ivaldi, G. B.
    Leonardi, M.
    Ferrari, A.
    Morra, A.
    Fossa, B. Jereczek
    Vavassori, A.
    Santoro, L.
    Orecchia, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S180 - S181
  • [8] Predictive factors for anthracycline-based chemotherapy for human breast cancer
    Miyoshi, Yasuo
    Kurosumi, Masafumi
    Kurebayashi, Junichi
    Matsuura, Nariaki
    Takahashi, Masato
    Tokunaga, Eriko
    Egawa, Chiyomi
    Masuda, Norikazu
    Kono, Seishi
    Morimoto, Koji
    Kim, Seung Jin
    Okishiro, Masatsugu
    Yanagisawa, Tetsu
    Ueda, Satsuki
    Taguchi, Tetsuya
    Tamaki, Yasuhiro
    Noguchi, Shinzaburo
    BREAST CANCER, 2010, 17 (02) : 103 - 109
  • [9] Predictive factors for anthracycline-based chemotherapy for human breast cancer
    Yasuo Miyoshi
    Masafumi Kurosumi
    Junichi Kurebayashi
    Nariaki Matsuura
    Masato Takahashi
    Eriko Tokunaga
    Chiyomi Egawa
    Norikazu Masuda
    Seishi Kono
    Koji Morimoto
    Seung Jin Kim
    Masatsugu Okishiro
    Tetsu Yanagisawa
    Satsuki Ueda
    Tetsuya Taguchi
    Yasuhiro Tamaki
    Shinzaburo Noguchi
    Breast Cancer, 2010, 17 : 103 - 109
  • [10] Biological prognostic factors for disease free survival in breast cancer patients treated with adjuvant anthracycline chemotherapy
    Biesacia, B.
    Niemiec, J.
    Ziobro, Z.
    Wysocka, J.
    Kruczak, A.
    EJC SUPPLEMENTS, 2008, 6 (09): : 156 - 156
12345